Identifying SARS-CoV-2 genome details and achieving treatment goals - Khashei Varnamkhasti, Khalil;Naeimi, Sirous
26,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

A novel disease, of unknown origin, causing a deadly pneumonia of human patients was reported in December 2019 in Wuhan, Hubei province of China. Later called coronavirus disease (COVID-19), it rapidly spread across China and worldwide. Intensive research revealed that the etiological agent of the global COVID-19 pandemic was a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 genome contains typical coronavirus genes but has some notable differences. The knowledge of the structural components of the virus genome provides an opportunity to identify various drug target areas.…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
A novel disease, of unknown origin, causing a deadly pneumonia of human patients was reported in December 2019 in Wuhan, Hubei province of China. Later called coronavirus disease (COVID-19), it rapidly spread across China and worldwide. Intensive research revealed that the etiological agent of the global COVID-19 pandemic was a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 genome contains typical coronavirus genes but has some notable differences. The knowledge of the structural components of the virus genome provides an opportunity to identify various drug target areas.
Autorenporträt
Dr. Khalil Khashei Varnamkhasti, doctor en genética molecular. Dr. Sirous Naeimi, Profesor Adjunto de Genética Molecular. Presidente del Departamento de Genética, Universidad Islámica Azad, sucursal de kazerun, kazerun, Irán.